Sorrento Therapeutics, Inc.
OTC: SRNE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Henry H. Ji
- Employees
- 949
- Headquarters
- San Diego, United States
- IPO year
- 2007
- Market cap
- $551.3K
- Website
- https://www.sorrentotherapeutics.com
Loading SRNE…
Loading profile data…Frequently asked questions about SRNE
What does Sorrento Therapeutics, Inc. (SRNE) do?
Sorrento Therapeutics, Inc. is a biopharmaceutical company, active in both clinical development and commercial operations, dedicated to creating treatments for a range of serious conditions including cancer, autoimmune disorders, inflammatory diseases, viral infections, and neurodegenerative ailments. The company's operations are divided into tw...
Where does SRNE trade?
Sorrento Therapeutics, Inc. (SRNE) trades on the Other OTC.
What sector is SRNE in?
Sorrento Therapeutics, Inc. (SRNE) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Sorrento Therapeutics, Inc.?
Henry H. Ji is the chief executive officer of Sorrento Therapeutics, Inc. (SRNE).
Where is Sorrento Therapeutics, Inc. headquartered?
Sorrento Therapeutics, Inc. is headquartered in United States.
Does SRNE pay a dividend?
Sorrento Therapeutics, Inc. (SRNE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SRNE go public?
Sorrento Therapeutics, Inc. (SRNE) completed its initial public offering in 2007.